Abbvie (ABBV) PT Raised to $242 at Guggenheim, 'Looking for Additional Treats on Halloween to Drive Further Upside'
Tweet Send to a Friend
Guggenheim analyst Vamil Divan raised the price target on Abbvie (NYSE: ABBV) to $242.00 (from $227.00) while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
